| Literature DB >> 34550569 |
Olivier Piguet1,2, Rebekah M Ahmed3,4, Fiona Kumfor5.
Abstract
Administration of intranasal oxytocin has been found to improve social cognition in a number of brain conditions, including autism spectrum disorder and schizophrenia. Whether this approach is relevant in dementias is currently unknown, particularly in frontotemporal dementia, a younger-onset dementia characterized clinically by marked changes in social cognition and behavior and focal atrophy of the frontal and temporal lobes. This chapter provides an overview of the deficits in social cognition in frontotemporal dementia and reviews the emerging evidence of intranasal oxytocin administration as a potential treatment option for these deficits. Future research directions will also be discussed.Entities:
Keywords: Alzheimer’s disease; Emotion procession; Empathy; Frontotemporal dementia; Hypothalamus; Neuroimaging; Progressive nonfluent aphasia; Semantic dementia; Social cognition
Mesh:
Substances:
Year: 2022 PMID: 34550569 DOI: 10.1007/978-1-0716-1759-5_5
Source DB: PubMed Journal: Methods Mol Biol ISSN: 1064-3745